Shangya Technology Co (6130.TWO) Osake Kurssi

Xingbao International Co., Ltd. engages in the development of biomedical products. The company is headquartered in Taipei City, Taipei. The company went IPO on 2002-01-02. The businesses include Western medicine trading, solar power generation, real estate leasing, and power integrated circuit (IC) design, production, and sales. The company sells products directly or through distributors to medical centers, public hospitals, foundation hospitals and clinics, pharmacies. The company sells power to Taiwan power companies. The sales targets also include company line numbers and individuals. Products include nervous system drugs, antineoplastic drugs, hypoglycemic drugs, cardiovascular system drugs, respiratory drugs, sexual dysfunction drugs, non-infectious pain relievers and anti-inflammatory drugs and hepatitis drugs. Solar energy is used for electricity supply. Power ICs are used in mobile phones, tablet charging chips, Type C expansion houses, industrial control equipment, televisions, personal computers and notebook computers, automobiles and smart fan control.